Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

SAN JOSE, Calif., March 2, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its CEO, Dr. Amit Kumar, will provide a corporate presentation on the company,...

Click to view original post